4D Train

4D pharma to Participate in Ladenburg Thalmann Healthcare Conference

Retrieved on: 
Tuesday, June 29, 2021
Science, Biotechnology, Research, Pharmaceutical, Oncology, General Health, Health, Clinical trials, Bacteriology, Computer programming, 4th Dimension, Cross-platform software, Computing, Software engineering, Bacteria, 4D Train

A webcast of the presentation will be available via the Events section of the 4D pharma website at www.4dpharmaplc.com .

Key Points: 
  • A webcast of the presentation will be available via the Events section of the 4D pharma website at www.4dpharmaplc.com .
  • An archived replay of the webcast will be available for 90 days following the presentation.
  • 4D has developed a proprietary platform, MicroRx, that rationally identifies Live Biotherapeutics based on a deep understanding of function and mechanism.
  • 4D pharma's Live Biotherapeutic products (LBPs) are orally delivered single strains of bacteria that are naturally found in the healthy human gut.

4D Molecular Therapeutics Announces Preclinical Data Presentations at ASGCT and ATS Annual Meetings on Three Wholly-Owned Product Candidates from Non-Human Primate Studies

Retrieved on: 
Tuesday, April 27, 2021
Computer programming, Communication, Forward-looking statement, 4th Dimension, 4D Train, Computing, Software, Computer programming, Communication, Forward-looking statement, 4th Dimension, 4D Train, Computing, Software

The company is initially focused in three therapeutic areas: ophthalmology, cardiology, and pulmonology.

Key Points: 
  • The company is initially focused in three therapeutic areas: ophthalmology, cardiology, and pulmonology.
  • In addition, any forward-looking statements represent 4DMT\'s views only as of today and should not be relied upon as representing its views as of any subsequent date.
  • 4DMT explicitly disclaims any obligation to update any forward-looking statements.
  • No representation is made as to the safety or effectiveness of 4D-310, 4D-125, or 4D-110 for the therapeutic use for which they are being studied.\n'

4D Pharma Presents Update on Oncology Program

Retrieved on: 
Wednesday, February 3, 2021
Biotechnology, Health, Pharmaceutical, Clinical trials, Oncology, Corporate finance, Private equity, Special-purpose acquisition company, 4D Train

4D pharma has continued to make excellent progress with the MRx0518 development program on multiple fronts.

Key Points: 
  • 4D pharma has continued to make excellent progress with the MRx0518 development program on multiple fronts.
  • This clinical and development progress has been achieved in spite of the headwinds of COVID-19, said Dr. Alex Stevenson, Chief Scientific Officer, 4D pharma.
  • As 4D pharma extends its leading position in this exciting and rapidly maturing field, we see the next 12 months as being instrumental for the space.
  • In October 2020 4D pharma announced its intention to merge with Longevity Acquisition Corporation (NASDAQ: LOAC), a special purpose acquisition company (SPAC), and seek a NASDAQ listing.

4D Vision Light Launches Initial License offering on the ILOCX and Signs Joint Venture with ConFlow Power Group

Retrieved on: 
Thursday, October 22, 2020
Computing, Computer programming, 4D Train, 4th Dimension, Software, Royalty payment, 4D

4D Vision Lightis offering the first round of 25,000 licenses at $20.00 per license in exchange for 10% of their revenue paid as a royalty to the license holders pool.

Key Points: 
  • 4D Vision Lightis offering the first round of 25,000 licenses at $20.00 per license in exchange for 10% of their revenue paid as a royalty to the license holders pool.
  • The Joint Venture has been signed on the heels of the successful demonstration of the 4D prototype unveiled to the ConFlow team last month.
  • Jonathan Jacques, president and 4D Vision founder said: "We have been working closely with ILOCX and ConFlow for many months to bring this Joint Venture to life.
  • We are thrilled and energized to be here now as we begin our Joint Venture with ConFlow with an initial commercial installation envisaged early next year.

4D Vision Light Launches Initial License offering on the ILOCX and Signs Joint Venture with ConFlow Power Group

Retrieved on: 
Thursday, October 22, 2020
Computing, Computer programming, 4D Train, 4th Dimension, Software, Royalty payment, 4D

4D Vision Lightis offering the first round of 25,000 licenses at $20.00 per license in exchange for 10% of their revenue paid as a royalty to the license holders pool.

Key Points: 
  • 4D Vision Lightis offering the first round of 25,000 licenses at $20.00 per license in exchange for 10% of their revenue paid as a royalty to the license holders pool.
  • The Joint Venture has been signed on the heels of the successful demonstration of the 4D prototype unveiled to the ConFlow team last month.
  • Jonathan Jacques, president and 4D Vision founder said: "We have been working closely with ILOCX and ConFlow for many months to bring this Joint Venture to life.
  • We are thrilled and energized to be here now as we begin our Joint Venture with ConFlow with an initial commercial installation envisaged early next year.

Aeva Reveals First 4D LiDAR on Chip for Autonomous Driving and Vote of Confidence from VW Group with Porsche SE Investment

Retrieved on: 
Wednesday, December 11, 2019
Technology, Alternative Vehicles, Fuels, Semiconductor, Automotive, Engineering, Manufacturing, Other Automotive, Software, Hardware, Emerging technologies, Technology, Lidar, Robotic sensing, Articles, Self-driving car, 4D Train

Unlike other LiDAR technologies, Aevas 4D LiDAR-on-chip measures the instant velocity of every point on objects beyond 300m.

Key Points: 
  • Unlike other LiDAR technologies, Aevas 4D LiDAR-on-chip measures the instant velocity of every point on objects beyond 300m.
  • This investment is Porsche SEs only investment in LiDAR technology and expands on the existing partnership between Aeva and Audis self-driving unit.
  • Together we are looking into using Aevas 4D LiDAR for our VW ID Buzz AV, which is scheduled to launch in 2022/23.
  • Aevas next generation 4D LiDAR system, Aeries, features a 120-degree field-of-view at only half the size of Aevas first product.